These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8386898)

  • 1. Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine.
    Chariot P; Benbrik E; Schaeffer A; Gherardi R
    Acta Neuropathol; 1993; 85(4):431-6. PubMed ID: 8386898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy.
    Chariot P; Gherardi R
    Neuromuscul Disord; 1991; 1(5):357-63. PubMed ID: 1668320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
    Chariot P; Bonne G; Authier FJ; Marsac C; Gherardi R
    J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P; Le Maguet F; Authier FJ; Labes D; Poron F; Gherardi R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
    Schröder JM; Bertram M; Schnabel R; Pfaff U
    Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits.
    Yerroum M; Pham-Dang C; Authier FJ; Monnet I; Gherardi R; Chariot P
    Acta Neuropathol; 2000 Jul; 100(1):82-6. PubMed ID: 10912924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
    N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
    Dalakas MC; Leon-Monzon ME; Bernardini I; Gahl WA; Jay CA
    Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AZT-induced mitochondrial myopathy.
    Tomelleri G; Tonin P; Spadaro M; Tilia G; Orrico D; Barelli A; Bonetti B; Monaco S; Salviati A; Morocutti C
    Ital J Neurol Sci; 1992 Dec; 13(9):723-8. PubMed ID: 1336487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
    Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS; Winer J; Landon DN; Stotter A; Pinching AJ
    Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.
    Panegyres PK; Papadimitriou JM; Hollingsworth PN; Armstrong JA; Kakulas BA
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):649-55. PubMed ID: 2170584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment.
    Cornford ME; Ho HW; Vinters HV
    Acta Neuropathol; 1992; 84(5):516-29. PubMed ID: 1334328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal cytochrome c oxidase deficiency in various neuromuscular diseases.
    Yamamoto M; Koga Y; Ohtaki E; Nonaka I
    J Neurol Sci; 1989 Jun; 91(1-2):207-13. PubMed ID: 2545831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
    Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.
    Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV
    J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine.
    Herzberg NH; Zorn I; Zwart R; Portegies P; Bolhuis PA
    Muscle Nerve; 1992 Jun; 15(6):706-10. PubMed ID: 1324428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine.
    Casoli C; Magnani G; Schianchi C; Barchi E; Bertazzoni U
    AIDS; 1990 Aug; 4(8):799-802. PubMed ID: 2261134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.